Yes, it is coming very quickly. MAB shortage with just Lily & Regeneron supply thru end of year. HGEN is manufacturing doses and will not only be ready to get into the fight, but might be absolutely necessary to cleanup the mess. Cannot wait to see Phase III Data, and I'd guess the FDA may already know. The most recent case study released was Highly Impressive. Let's get Lenzilumab to work!